IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Investidor Profissional Gestao de Recursos Ltda.

Key Points

• Investidor Profissional Gestao de Recursos Ltda. increased its shares in IDEXX Laboratories by 206.0% in Q1, bringing its total to 3,635 shares valued at $1,527,000.
• Multiple institutional investors, including Atria Wealth Solutions and Wealthspire Advisors, have also increased their stakes in IDEXX Laboratories, highlighting renewed investor interest.
• IDEXX Laboratories reported a strong quarterly performance with an EPS of $3.63, exceeding estimates and demonstrating a 10.6% revenue increase from the previous year.

Investidor Profissional Gestao de Recursos Ltda. boosted its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 206.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,635 shares of the company's stock after purchasing an additional 2,447 shares during the period. IDEXX Laboratories makes up 1.0% of Investidor Profissional Gestao de Recursos Ltda.'s holdings, making the stock its 14th biggest holding. Investidor Profissional Gestao de Recursos Ltda.'s holdings in IDEXX Laboratories were worth $1,527,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of IDXX. MorganRosel Wealth Management LLC acquired a new stake in IDEXX Laboratories during the first quarter worth $26,000. Migdal Insurance & Financial Holdings Ltd. increased its position in shares of IDEXX Laboratories by 55.6% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 84 shares of the company's stock worth $35,000 after purchasing an additional 30 shares during the last quarter. Colonial Trust Co SC raised its holdings in IDEXX Laboratories by 84.8% in the 4th quarter. Colonial Trust Co SC now owns 85 shares of the company's stock valued at $35,000 after buying an additional 39 shares during the period. Bank of Jackson Hole Trust lifted its position in IDEXX Laboratories by 328.6% in the first quarter. Bank of Jackson Hole Trust now owns 90 shares of the company's stock valued at $39,000 after buying an additional 69 shares during the last quarter. Finally, Itau Unibanco Holding S.A. boosted its stake in IDEXX Laboratories by 540.0% during the fourth quarter. Itau Unibanco Holding S.A. now owns 96 shares of the company's stock worth $40,000 after buying an additional 81 shares during the period. 87.84% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently commented on IDXX shares. Wall Street Zen upgraded IDEXX Laboratories from a "hold" rating to a "buy" rating in a research report on Saturday, July 12th. Leerink Partners increased their price objective on shares of IDEXX Laboratories from $580.00 to $600.00 and gave the company an "outperform" rating in a research report on Thursday, July 17th. BTIG Research boosted their target price on shares of IDEXX Laboratories from $545.00 to $785.00 and gave the stock a "buy" rating in a research note on Tuesday. Morgan Stanley set a $722.00 price objective on IDEXX Laboratories and gave the stock an "overweight" rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. raised their target price on IDEXX Laboratories from $550.00 to $675.00 and gave the stock an "overweight" rating in a research report on Monday. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, IDEXX Laboratories currently has an average rating of "Moderate Buy" and an average target price of $623.56.

Insiders Place Their Bets

In other IDEXX Laboratories news, Director M Anne Szostak sold 1,260 shares of the business's stock in a transaction on Wednesday, May 21st. The stock was sold at an average price of $512.34, for a total transaction of $645,548.40. Following the sale, the director directly owned 1,801 shares in the company, valued at approximately $922,724.34. The trade was a 41.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.98% of the company's stock.

IDEXX Laboratories Stock Performance

NASDAQ IDXX traded down $17.75 during trading hours on Wednesday, hitting $624.19. 816,294 shares of the stock were exchanged, compared to its average volume of 770,026. IDEXX Laboratories, Inc. has a 12-month low of $356.14 and a 12-month high of $688.12. The stock has a 50-day moving average of $537.43 and a 200 day moving average of $475.11. The company has a market cap of $50.20 billion, a price-to-earnings ratio of 51.97, a price-to-earnings-growth ratio of 4.32 and a beta of 1.49. The company has a quick ratio of 0.81, a current ratio of 1.11 and a debt-to-equity ratio of 0.31.

IDEXX Laboratories (NASDAQ:IDXX - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $3.63 EPS for the quarter, beating the consensus estimate of $3.28 by $0.35. IDEXX Laboratories had a return on equity of 64.42% and a net margin of 24.41%. The business had revenue of $1.11 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same period last year, the firm earned $2.44 EPS. The company's quarterly revenue was up 10.6% compared to the same quarter last year. As a group, equities research analysts forecast that IDEXX Laboratories, Inc. will post 11.93 earnings per share for the current year.

IDEXX Laboratories Company Profile

IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.